Rachel E. Savage

Rachel E. Savage

Auto-generated profile, based on publicly available information

Rachel E. Savage

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Annual Review of Cancer Biology
Verified
Journal Article
Open access
LLLindsay M. LaFave
Lindsay M. LaFave
RSRachel E. Savage
Rachel E. Savage
JBJason D. Buenrostro
Jason D. Buenrostro
Cancer initiation is driven by the cooperation between genetic and epigenetic aberrations that disrupt gene regulatory programs critical to maintain specialized cellular functions. After initiation, cells acquire additional genetic and epigenetic alterations influenced by tumor-intrinsic and -extrinsic mechanisms, which increase intratumoral heterogeneity, reshape the cell's underlying gene regulatory network, and promote cancer evolution. Furthermore, environmental or therapeutic insults drive the selection of heterogeneous cell states, with implications for cancer initiation, maintenance, and drug resistance. The advancement of single-cell genomics has begun to uncover the full repertoire of chromatin and gene expression states (cell states) that exist within individual tumors. These single-cell analyses suggest that cells diversify in their regulatory states upon transformation by co-opting damage-induced and nonlineage regulatory programs that can lead to epigenomic plasticity. Here, we review these recent studies related to regulatory state changes in cancer progression and highlight the growing single-cell epigenomics toolkit poised to address unresolved questions in the field. Expected final online publication date for the Annual Review of Cancer Biology, Volume 6 is April 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

22 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRachel E. Savage
Rachel E. Savage
CAChristian D. McRoberts Amador
Christian D. McRoberts Amador
CHConrad T. Hock
Conrad T. Hock
RZRuochi Zhang
Ruochi Zhang
HKHung-Che Kuo
Hung-Che Kuo
JBJason D. Buenrostro
Jason D. Buenrostro
Transcription factors (TFs) collaborate to regulate gene expression programs that define cell fate. In CD8 + T cells, this coordinated regulation underlies exhaustion, a dysfunctional state that constrains immunity in chronic infection and cancer. Here, we screen for cell state-specific TFs by performing pooled overexpression screens of 3,548 TF and TF isoforms in primary T cells across multiple CD8 + T cell states. We identify 82 regulators that collaborate with exhaustion-specific programs and profile their effects using perturb-SHARE-seq, connecting perturbations to changes in chromatin accessibility and gene expression across 702,314 single cells. We identify 38 reproducible regulatory programs and construct a map of 12,616 TF-program connections that shape CD8 + T cell states, nominating KLF2 as predictive of positive response to CAR-T therapy. Using seq2PRINT, a deep learning framework that predicts functional TF interactions, we identify RUNX as a “master collaborator”, a TF that broadly collaborates with other factors, and uncover a RUNX2:KLF2 interaction that specifies exhaustion-associated programs. Mutation of the RUNX2:KLF2 protein interface attenuates KLF2-mediated repression of exhaustion, while synthetic tethering of RUNX2 to KLF2 leads to an amplification of the phenotype. More broadly, we identify the collaborative action of RUNX as a driver in CD8 + T cell states, and show that tethering TFs enables the rational engineering of cell state identity for cell and gene therapies.